|
1.
|
C-reactive protein, fibrinogen, and cardiovascular disease prediction. MedStar authors:
Citation: - New England Journal of Medicine. 367(14):1310-20, 2012 Oct 4.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Butterworth AS, Caslake M, Clarke R, Cooper JA, Cremer P, Cushman M, D'Agostino RB Sr, Dagenais GR, Danesh J, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Di Angelantonio E, Emerging Risk Factors Collaboration, Engstrom G, Folsom AR, Ford I, Fowkes FG, Gallacher J, Gao P, Gaziano JM, Giampaoli S, Gillum RF, Gudnason V, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kaptoge S, Kauhanen J, Khaw KT, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Lowe GD, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Packard CJ, Panagiotakos DB, Pennells L, Pepys MB, Psaty BM, Ridker PM, Rodriguez B, Rosengren A, Salomaa V, Salonen JT, Sarwar N, Sattar N, Shaffer JA, Shea S, Stehouwer CD, Strandberg TE, Thompson A, Thompson SG, Tipping RW, Tosetto A, Walker M, Wareham NJ, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, White IR, Wilhelmsen L, Wood AM, Woodward M
|
|
4.
|
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. MedStar authors:
Year: 2017
Citation: - New England Journal of Medicine. 376(20):1933-1942, 2017 05 18
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - ACCELERATE Investigators, Barter PJ, Brewer HB, Conde D, Fox KAA, Gibson CM, Goodman SG, Granger C, Kandath D, Kouz S, Leiva-Pons JL, Li W, Lincoff AM, Mason D, McErlean E, McGuire DK, Menon V, Montalescot G, Nicholls SJ, Nicolau JC, Nissen SE, Pesant Y, Rader D, Riesmeyer JS, Ruotolo G, Tahirkheli N, Tall AR, Vangerow B, Weerakkody G, Wolski K
|